# FDA Inspection 1215345 - GlaxoSmithKline Biologicals SA - June 23, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/glaxosmithkline-biologicals-sa/f7edf2ba-9037-4e72-9ab4-12d46616e90c/
Source feed: FDA_Inspections

> FDA Inspection 1215345 for GlaxoSmithKline Biologicals SA on June 23, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1215345
- Company Name: GlaxoSmithKline Biologicals SA
- Inspection Date: 2023-06-23
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1304664 - 2026-02-27](https://www.globalkeysolutions.net/api/records/fda_inspections/glaxosmithkline-biologicals-sa/a737c389-4e6a-4fcc-94cb-27544c5ade52/)
- [FDA Inspection 1007184 - 2017-01-27](https://www.globalkeysolutions.net/api/records/fda_inspections/glaxosmithkline-biologicals-sa/70cb7ce5-0715-4ec4-8b61-c997bb03b824/)
- [FDA Inspection 900625 - 2014-10-02](https://www.globalkeysolutions.net/api/records/fda_inspections/glaxosmithkline-biologicals-sa/9e518157-9df1-4b38-9fdf-fe6d1dfe4269/)
- [FDA Inspection 818683 - 2012-10-05](https://www.globalkeysolutions.net/api/records/fda_inspections/glaxosmithkline-biologicals-sa/b6c161d8-1307-454f-8246-b21976212187/)
- [FDA Inspection 672159 - 2010-06-03](https://www.globalkeysolutions.net/api/records/fda_inspections/glaxosmithkline-biologicals-sa/4295eb06-bce8-47d9-b105-1abe6654554a/)

Company: https://www.globalkeysolutions.net/companies/glaxosmithkline-biologicals-sa/ef569005-49c7-4bf9-b3f1-7814705bec8e

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d